Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
JACKSONVILLE, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer James M. Foote will address the 2020 Stephens Annual Investment Conference...
-
LOUISVILLE, Ky., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Appriss Insights, a leading technology, data and analytics provider, today introduced ProviderSafe™, a new set of wholesale solutions designed to...
-
TAMPA, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) -- System Soft Technologies (SSTech), a leader in enterprise IT services, solutions and products, today announced the company is hosting a webinar at 2:30...
-
New York, New York, Nov. 10, 2020 (GLOBE NEWSWIRE) -- New York Film Academy (“NYFA”) will kick off the first day of Transgender Awareness Week with an online Q&A with award-winning director...
-
GAITHERSBURG, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, will host a...
-
Event attendees will start each day getting insights and inspiration from industry leaders including ASME, Medical Alley, IoPP, SPE, and the Mayo Clinic.To register to attend Virtual Engineering Week,...
-
BOCA RATON, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a globally focused, multi-state cannabis and hemp operator, today...
-
FORT WASHINGTON, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, will broadcast live on its website, www.TollBrothers.com, a...
-
LA JOLLA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
-
ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor...